Constantino, Lemar D.

HRN: 23-41-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/04/2023
09/12/2023
IV
500mg
Q8
Hemorrhoids
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: